KamfaninTarihi

An ba da babbar lambar yabo ta "SRDI (Na musamman, Mai ladabi, Bambanci, Innovative) Enterprise" da kuma "Innovative SME", ingantattun damar mu - iyawar R&D da tsayin daka a cikin sashin IVD na duniya.

An tabbatar da shi a hukumance azaman Babban Babban Lardi Na'urorin gwajin mugun gashi na zamani an ƙirƙira su ne kawai a cikin babban adireshin saye na Ma'aikatar Tsaro ta Jama'a.

An sami babban shigar duniya tare da samfuran da aka rarraba a cikin ƙasashe 40+. Alamar "LYHER®" ta sami amintaccen rajistar alamar kasuwanci a cikin manyan kasuwanni 18, gami da EU, Amurka, Brazil, da Japan.

Nasarar wuce ƙaƙƙarfan kimanta ma'aikatar Tsaro ta Jama'a don gano maganin gashi. An sami amintaccen babban fayil na kayan fasaha wanda ya ƙunshi haƙƙin ƙirƙira na duniya guda 8, ƙirar ƙira 10, da haƙƙin mallaka na software 5.

Ƙoƙarin mayar da martani na annoba tare da gudummawar kayan gwaji sama da 100,000 a duniya. An sami amincewar ka'idoji na kasa da kasa na farko, gami da US FDA EUA, BfArM na Jamus, da ANSM na Faransa.

An karrama shi a matsayin "AAA - Ingancin Matsayi - Kasuwancin Madaidaici da Amintacce," yana nuna ƙaddamar da ƙaddamarwar mu ga tsauraran tsarin sarrafa inganci da ɗa'a, ayyukan kasuwanci na gaskiya.

Anyi nasarar yin rijista da ƙaddamar da na'urorin likitanci na Class III 6. An karrama Laihe a hukumance tare da “National High - Tech Enterprise” takaddun shaida, shaida ga ci gaba da ci gaban fasaharmu.

An ba da wasu muhimman haƙƙin mallaka guda bakwai don fasahar bincike. Babban gwajin mu na Magungunan Abuse (DOA) na gaggawa an ƙididdige su a ƙa'ida a cikin ma'aikatar Tsaron Jama'a ta shawarar anti- miyagun ƙwayoyi.

An share tsayayyen ISO 13485 da ka'idodin yarda da CE, wanda ke nuna ƙaddamar da ayyukan mu na fitarwa na duniya a hukumance da kuma kawo manyan hanyoyin tantance amincin aminci ga kasuwannin duniya.

An kafa Hangzhou Laihe Biotech Co., Ltd., nan da nan ya lashe babban aikin tallafawa "Hangzhou 5050 Overseas High - Level Talents". Nasarar samun Babban Lasisin Samar da Na'urar Likitanmu.